Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
Military troops take doxycycline to prevent infections and malaria, and teenagers use it to treat acne. Wilmot Cancer Institute scientists are also testing it for the treatment of lymphoma.
7/24/2014 | 0 comments
A bit of summer trivia: After George H. Whipple won the 1934 Noble Prize for his discoveries regarding anemia, what happened to his original, handwritten notes?
7/17/2014 | 0 comments
UR scientist Lisa Beck, M.D., led a clinical investigation for a new drug to treat eczema or atopic dermatitis, with encouraging results that were reported in the New England Journal of Medicine.
7/10/2014 | 0 comments
Antibiotics given to preterm newborns disrupt the diversity of gut bacteria, but a shorter, two-day course of drugs has less impact than seven days or more of antibiotics, according to a study from a team in Pediatrics at UR Medicine’s Golisano Children’s Hospital.
7/2/2014 | 1 comment
The National Cancer Institute awarded more than $2 million to a team at the Wilmot Cancer Institute to continue their study of a gene network that controls cancer progression, with a focus on pancreatic cancer.
6/25/2014 | 0 comments